Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome
- Authors: Tsukanov VV1, Rzhavicheva OS1, Vasjutin AV1, Dunaevskaja OV1, Tonkih J.L1, Bronnikova EP1
-
Affiliations:
- Issue: Vol 88, No 8 (2016)
- Pages: 40-45
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/32063
- DOI: https://doi.org/10.17116/terarkh201688840-45
- ID: 32063
Cite item
Full Text
Abstract
Keywords
About the authors
V V Tsukanov
O S Rzhavicheva
A V Vasjutin
O V Dunaevskaja
Ju L Tonkih
E P Bronnikova
References
- Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377-1390. doi: 10.1053/j.gastro.2006.03.008
- Porter CK, Gormley R, Tribble DR, Cash BD, Riddle MS. The Incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population. Am J Gastroenterol. 2011;106(1):130-138. doi: 10.1038/ajg.2010.371
- El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. 2012;18(37):5151-5163. doi: 10.3748/wjg.v18.i37.5151
- Bashashati M, Rezaei N, Shafieyoun A, McKernan DP, Chang L, Öhman L, Quigley EM, Schmulson M, Sharkey KA, Simrén M. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014;26(7):1036-1048. doi: 10.1111/nmo.12358
- Darkoh C, Comer L, Zewdie G, Harold S, Snyder N, Dupont HL. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One. 2014;9(3):e93144. doi: 10.1371/journal.pone.0093144
- Маев И.В., Черемушкин С.В., Кучерявый Ю.А., Черемушкина Н.В. Фармакотерапия синдрома раздраженного кишечника с позиций доказательной медицины. Терапевтический архив. 2015;87(2):4-10.
- Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(22):6759-6773. doi: 10.3748/wjg.v20.i22.6759
- Эпштейн О.И. Релиз-активность — от феномена до создания новых лекарственных средств. Бюллетень экспериментальной биологии и медицины. 2012;154(7):62-67.
- Осадчук М.А. Колофорт — новый препарат в терапии функциональных расстройств кишечника. Медицинский Альманах. 2015;1(36):57-59.
- Lacy BE, Chey WD, Lembo AJ. New and Emerging Treatment Options for Irritable Bowel Syndrome. Gastroenterol Hepatol (NY). 2015;11(4 Suppl. 2):1-19.
- Woutersen-Koch H, Smout AJ, Flik C, Hulshof CT, de Wit NJ, van der Horst HE. Multidisciplinary guideline irritable bowel syndrome. Ned Tijdschr Geneeskd. 2013;156(0):A4584.
- Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015;50(1):11-30. doi: 10.1007/s00535-014-1017-0